Latest Articles
Worker at former Marsden Point refinery flown to hospital after medical emergency - RNZ
Worker at former Marsden Point refinery flown to hospital after medical emergency RNZ
Published: June 18, 2026, 6:20 a.m.
Clarifying Factors That Inform MIGS Versus Open Procedure - Cleveland Clinic
Clarifying Factors That Inform MIGS Versus Open Procedure Cleveland Clinic
Published: June 18, 2026, 6:11 a.m.
Doctor Shares Infuriating Studies On Endometriosis And People Can’t Believe How Bad They Are - TVovermind
Doctor Shares Infuriating Studies On Endometriosis And People Can’t Believe How Bad They Are TVovermind
Published: June 18, 2026, 3:16 a.m.
Armed police swarmed Christchurch street, arrest one person - RNZ
Armed police swarmed Christchurch street, arrest one person RNZ
Published: June 18, 2026, 12:59 a.m.
SA confirms nation-first media literacy program's rollout to all primary schools - psnews.com.au
SA confirms nation-first media literacy program's rollout to all primary schools psnews.com.au
Published: June 17, 2026, 9:23 p.m.
Sun Pharma to acquire Organon in US$11bn deal - FemTech World
Sun Pharma to acquire Organon in US$11bn deal FemTech World
Published: June 17, 2026, 10:47 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted
Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Link copied to clipboard!